We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA has granted Cour Pharmaceuticals orphan drug ...
CenterPoint Energy CNP benefits from rising electricity consumption, driven by the rapid electrification of transportation and buildings, along with increasing investments in renewable energy. Given ...
Ascendis Pharma A/S (NASDAQ:ASND) executives highlighted topline Week 52 results from the company’s Phase 2 COACH trial, ...
At first glance, the CNP and its lobbying arm, CNP Action, appear to be relatively modest operations. The Council for National Policy’s 990 tax form for 2019, the most recent available, reports a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback